CD276 and endometrial cancer: To determine the potential of CC-3 in endometrial cancer, as a first step CD276 mRNA expression was analyzed in a TCGA dataset of 174 endometrial cancer samples and compared with 91 healthy tissue samples, showing higher expression in cancer samples (Fig. 1B).